PRC
MRNA icon

Pearl River Capital’s Moderna MRNA Stock Holding History

Pearl River Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,006
Closed -$594K – 236
2024
Q2 		$594K Buy
+5,006
New +$633K 0.09% 252
2021
Q4 		– Sell
-2,200
Closed -$847K – 519
2021
Q3 		$847K Buy
+2,200
New +$811K 0.23% 141
2021
Q2 		– Sell
-6,718
Closed -$880K – 518
2021
Q1 		$880K Buy
6,718
+3,689
+122% +$535K 0.28% 115
2020
Q4 		$316K Buy
+3,029
New +$306K 0.11% 265
2020
Q3 		– Sell
-4,067
Closed -$261K – 425
2020
Q2 		$261K Buy
4,067
+2,432
+149% +$133K 0.13% 227
2020
Q1 		$49K Buy
+1,635
New +$37.6K 0.09% 237
2019
Q2 		– Sell
-3,168
Closed -$64K – 411
2019
Q1 		$64K Buy
+3,168
New +$58.8K 0.16% 219

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pearl River Capital's MRNA Position: Q3 2024 in Review

Pearl River Capital sold out of Moderna (MRNA) in Q3 2024, closing a stake of 5,006 shares — an estimated $594K sold.

Pearl River Capital first reported a position in MRNA in Q1 2019 and held it in 7 quarters. The position peaked at $880K in Q1 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Pearl River Capital reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Pearl River Capital sold 5,006 Moderna shares in Q3 2024, an estimated $594K.
  • Pearl River Capital first reported a position in Moderna in Q1 2019 and held it in 7 quarters.
  • Pearl River Capital's Moderna position peaked at $880K in Q1 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Pearl River Capital's 13F filing for Q3 2024.